NCT04232683View on ClinicalTrials.gov

Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 18, 2019

Primary Completion Date

October 11, 2025

Study Completion Date

December 31, 2025

Conditions
Urinary Retention
Interventions
DRUG

Tamsulosin 0.4Mg Capsule

Tamsulosin given preoperatively to detect if rates of urinary retention after female pelvic floor surgeries are decreased

DRUG

Placebo oral tablet

Placebo pill given preoperatively

Trial Locations (1)

33331

Cleveland Clinic Florida, Weston

All Listed Sponsors
lead

The Cleveland Clinic

OTHER